United States
Germany
Japan
United Kingdom
China
MAP2K1 (MEK1) mouse monoclonal antibody, clone OTI1E5 (formerly 1E5)
| Applications | IF, IHC, WB |
| Reactivities | Human, Dog, Rat, Monkey, Mouse |
Antibodies
MAP2K1 (MEK1) mouse monoclonal antibody, clone OTI2E8 (formerly 2E8)
| Applications | IF, IHC, WB |
| Reactivities | Human, Mouse, Rat |
MAP2K1 mouse monoclonal antibody, clone OTI9E9 (formerly 9E9)
| Applications | IF, IHC, WB |
| Reactivities | Human, Mouse, Rat |
MAP2K1 (MEK1) mouse monoclonal antibody, clone OTI5A11 (formerly 5A11)
| Applications | IF, IHC, WB |
| Reactivities | Human, Dog, Rat, Monkey, Mouse |
MAP2K1 (MEK1) mouse monoclonal antibody, clone OTI7B1 (formerly 7B1)
| Applications | IF, IHC, WB |
| Reactivities | Human, Dog, Rat, Monkey, Mouse |
MAP2K1 (MEK1) mouse monoclonal antibody, clone OTI4E4 (formerly 4E4)
| Applications | IF, IHC, WB |
| Reactivities | Human, Dog, Rat, Monkey, Mouse |
Rabbit anti-MEK1 Polyclonal Antibody
| Applications | ICC/IF, IHC, WB |
| Reactivities | Human, Mouse, Rat |
热销推荐
活动过滤器
优化搜索结果
Category
Reactivities
Antibody Hosts
Knockout (KO) Validation
Conjugates
Isotypes
Clonalities
Brands
Pathways
- Acute myeloid leukemia (182)
- B cell receptor signaling pathway (182)
- Bladder cancer (182)
- Chemokine signaling pathway (182)
- Chronic myeloid leukemia (182)
- Colorectal cancer (182)
- Dorso-ventral axis formation (182)
- Endometrial cancer (182)
- ErbB signaling pathway (182)
- Fc epsilon RI signaling pathway (182)
- Fc gamma R-mediated phagocytosis (182)
- Focal adhesion (182)
- Gap junction (182)
- Glioma (182)
- GnRH signaling pathway (182)
- Insulin signaling pathway (182)
- Long-term depression (182)
- Long-term potentiation (182)
- MAPK signaling pathway (182)
- Melanogenesis (182)
- Melanoma (182)
- Natural killer cell mediated cytotoxicity (182)
- Neurotrophin signaling pathway (182)
- Non-small cell lung cancer (182)
- Oocyte meiosis (182)
- Pancreatic cancer (182)
- Pathways in cancer (182)
- Prion diseases (182)
- Progesterone-mediated oocyte maturation (182)
- Prostate cancer (182)
- Regulation of actin cytoskeleton (182)
- Renal cell carcinoma (182)
- T cell receptor signaling pathway (182)
- Thyroid cancer (182)
- Toll-like receptor signaling pathway (182)
- VEGF signaling pathway (182)
- Vascular smooth muscle contraction (182)
